Oxford BioMedica (United Kingdom)

Oxford BioMedica (United Kingdom)

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Oxford BioMedica (United Kingdom), United Kingdom, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

80%


Total
Publications

6.7K


Total Open
Publications

5.3K


Total
Citations

394K


Open Access
Percentage

80%


Total
Publications

6.7K


Total Open
Publications

5.3K


Total
Citations

394K

Wikipedia

Website

download

Breakdown

10% 55% 14% 21%

Publisher Open

10%

Both

55%

Other Platform Open

14%

Closed

21%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0100200300400500600700Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

43%OA Journal

OA Journal 43%

1.9K

Hybrid 38%

1.6K

No Guarantees 19%

815

Other Platform Open

Institution 75%

3.4K

Domain 70%

3.2K

Other Internet 14%

640

Preprint 10%

460

Public 6%

264

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
3.3K
University of Oxford
Institution
1.4K
doaj.org OAI-PMH Repository
Institution
1.1K
DOI
Other Internet
456
Unknown Repository
Other Internet
378
University of Bristol
Institution
318
University of Edinburgh
Institution
303
University of Birmingham
Institution
298
Figshare
Public
275
University of Cambridge
Institution
244
1 / 20

Data updated 12 August 2026

Share

Share

Share